Shingrix 50 ug/.5mL
Zoster Vaccine Recombinant, Adjuvanted · INJECTION, SOLUTION · GlaxoSmithKline Biologicals SA
Shingrix is a injection, solution containing zoster vaccine recombinant, adjuvanted at 50 ug/.5mL, taken intramuscular. Manufactured by GlaxoSmithKline Biologicals SA.
Key Facts
- Brand Name
- Shingrix
- Generic Name
- Zoster Vaccine Recombinant, Adjuvanted
- NDC Code (Product)
58160-849- Manufacturer
- GlaxoSmithKline Biologicals SA
- Strength
- 50 ug/.5mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA125614
- Marketing Start
- 07/16/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is Shingrix used for?
Shingrix contains Zoster Vaccine Recombinant, Adjuvanted. It is a injection, solution taken intramuscular. Consult your doctor for specific uses.
Is Shingrix a controlled substance?
Shingrix is not classified as a controlled substance by the DEA.
What is the generic name for Shingrix?
The generic name for Shingrix is Zoster Vaccine Recombinant, Adjuvanted. There are no other listed brand versions of Zoster Vaccine Recombinant, Adjuvanted.
What is the NDC code for Shingrix 50 ug/.5mL?
The NDC (National Drug Code) for Shingrix 50 ug/.5mL is 58160-849, listed by GlaxoSmithKline Biologicals SA.
Other Shingrix Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)